Soaring Eagle Acquisition Corp.
NASDAQ Global SelectCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Harry Evans Sloan
- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- 2121 Avenue of the Stars Los Angeles CA United States of America
- IPO Date
- Feb 24, 2021
- CIK
- 0001830214
- Website
- eagleequityptnrs.com
- Similar Companies
- Business
- Soaring Eagle Acquisition Corp. specializes as a special purpose acquisition company (SPAC) focused on effecting mergers, share exchanges, asset acquisitions, share purchases, reorganizations, or similar business combinations with one or more businesses. The company was founded in 2020 and is headquartered in New York, New York. Its core business involves raising capital through public offerings to invest in target companies, without limiting the scope to any particular industry, sector, or geography. As a blank check company, it offers units comprising one share of common stock and partial warrants, facilitating strategic acquisitions. In February 2021, the company changed its name from Spinning Eagle Acquisition Corp to Soaring Eagle Acquisition Corp and completed an initial public offering raising approximately $1.725 billion. Soaring Eagle is led by CEO Harry E. Sloan and operates under the sponsorship of Eagle Equity Partners III, LLC, with notable investors including Jeff Sagansky and Eli Baker. The company raised $1.5 billion in its IPO, with Goldman Sachs as the lead manager, and sought to leverage its management team's extensive experience in global strategic investments, especially in sectors such as media and entertainment. The most significant recent change for Soaring Eagle Acquisition Corp. was its business combination with Ginkgo Bioworks Holdings, Inc., completed in a reverse merger transaction in September 2021. This merger resulted in Ginkgo Bioworks, a synthetic biology company, becoming publicly traded under the ticker symbol DNA on the New York Stock Exchange. The transaction was valued at approximately $17.8 billion, combining Soaring Eagle's capital trust and approximately $775 million in private investment in public equity (PIPE) proceeds. Post-merger, Soaring Eagle effectively operates as Ginkgo Bioworks Holdings, with a focus on engineered biology for applications in healthcare, agriculture, and industrial biosynthesis. The company's core products and services prior to the merger focused on providing acquisition and investment vehicles through SPAC mechanisms, while post-merger, the operations transitioned to Ginkgo Bioworks' synthetic biology platform offering cell engineering, organism development, and bio-product manufacturing services globally. Ginkgo partners with pharmaceutical, agriculture, and industrial companies to accelerate bioengineering projects, recently expanding collaborations, such as with Biogen for gene therapy and with Antheia for essential medicines production. Overall, Soaring Eagle Acquisition Corp. represents a well-capitalized SPAC vehicle with a strategic shift towards synthetic biology through its merger with Ginkgo Bioworks. It operates globally with a diversified approach to corporate acquisitions and investments and maintains its headquarters in New York City.
Ginkgo Bioworks to Go Public with Over $1.6 Billion in Proceeds
Ginkgo Bioworks to Go Public with Over $1.6 Billion in Proceeds
Cathie Wood Makes Adjustments to Portfolio in August
Soaring Eagle Announces Achievement of Quorum to Pass Proposed Business Combination with Ginkgo, Proxies Received Indicate Overwhelming Support for All Proposals
Soaring Eagle Announces Transfer of Listing to NYSE in Connection with its Proposed Business Combination with Ginkgo
Soaring Eagle Announces Transfer of Listing to NYSE in Connection with its Proposed Business Combination with Ginkgo
Soaring Eagle Announces Extraordinary General Meeting Date for Proposed Business Combination with Ginkgo
SPACs: Odds Still Favor the House, Unless You Know the Rules
Soaring Eagle Acquisition Corp., Led by Eagle Equity Partners’ Harry Sloan, Jeff Sagansky and Eli Baker Announces Separate Trading of its Class A Ordinary Shares and Warrants, Commencing on or about April 19, 2021
SRNGU Stock: 12 Things to Know About a Potential Ginkgo Bioworks SPAC Merger
8 Major Players in the SPAC Game to Watch
SRNGU Stock: Betting the Sponsors Is True SPAC Speculation
Soaring Eagle: Latest Offering From The Team Behind DraftKings, Skillz Business Combinations
Soaring Eagle Acquisition Corp., Led by Eagle Equity Partners’ Harry Sloan, Jeff Sagansky and Eli Baker Announces Completion of $1.725 billion IPO
Soaring Eagle Acquisition Corp., Led by Eagle Equity Partners' Harry Sloan, Jeff Sagansky and Eli Baker Announces Pricing of $1.5 Billion IPO
Soaring Eagle Acquisition Corp., Led by Eagle Equity Partners’ Harry Sloan, Jeff Sagansky and Eli Baker Announces Pricing of $1.5 Billion IPO